Upregulation of PTEN involved in scorpion venom-induced apoptosis in a lymphoma cell line

References

• Oukkache N, Rosso J P, Alami M, Ghalim N, Saile R, Hassar M, et al. New analysis of the toxic compounds from the Androctonus mauretanicus mauretanicus scorpion venom. Toxicon 2008; 51: 835–852
   PubMed Web of Science ®Google Scholar
• Feng L, Gao R, Gopalakrishnakone P. Isolation and characterization of a hyaluronidase from the venom of Chinese red scorpion Buthus martensi. Comp Biochem Physiol C Toxicol Pharmacol 2008; 148: 250–257
   PubMed Web of Science ®Google Scholar
• Verano-Braga T, Rocha-Resende C, Silva D M, Ianzer D, Martin-Eauclaire M F, Bougis P E, et al. Tityus serrulatus hypotensins: a new family of peptides from scorpion venom. Biochem Biophys Res Commun 2008; 371: 515–520
   PubMed Web of Science ®Google Scholar
• Mamelak A N, Jacoby D B. Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv 2007; 4: 175–186
   PubMed Web of Science ®Google Scholar
• Liu Y F, Hu J, Zhang J H, Wang S L, Wu C F. Isolation, purification, and N-terminal partial sequence of an antitumor peptide from the venom of the Chinese scorpion Buthus martensii Karsch. Prep Biochem Biotechnol 2002; 32: 317–327
   PubMed Web of Science ®Google Scholar
• Liu Y F, Ma R L, Wang S L, Duan Z Y, Zhang J H, Wu L J, et al. Expression of an antitumor-analgesic peptide from the venom of Chinese scorpion Buthus martensii karsch in Escherichia coli. Protein Expr Purif 2003; 27: 253–258
   PubMed Web of Science ®Google Scholar
• Das Gupta S, Debnath A, Saha A, Giri B, Tripathi G, Vedasiromoni J R, et al. Indian black scorpion (Heterometrus bengalensis Koch) venom induced antiproliferative and apoptogenic activity against human leukemic cell lines U937 and K562. Leuk Res 2007; 31: 817–825
   PubMed Web of Science ®Google Scholar
• Wang W X, Ji Y H. Scorpion venom induces glioma cell apoptosis in vivo and inhibits glioma tumor growth in vitro. J Neurooncol 2005; 73: 1–7
   PubMed Web of Science ®Google Scholar
• Weber A, Rahemtullah A, Ferry J. Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation. Neuroimaging Clin N Am 2003; 13: 371–392
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71–96
   PubMed Web of Science ®Google Scholar
• Mathew R, White E. FLIPping the balance between apoptosis and proliferation in thyroid cancer. Clin Cancer Res 2006; 12: 3648–3651
   PubMed Web of Science ®Google Scholar
• Evan G I, Vousden K H. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411: 342–348
   PubMed Web of Science ®Google Scholar
• Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang S I, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943–1947
   PubMed Web of Science ®Google Scholar
• Steck P A, Pershouse M A, Jasser S A, Yung W K, Lin H, Ligon A H, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15: 356–362
   PubMed Web of Science ®Google Scholar
• Myers M P, Stolarov J P, Eng C, Li J, Wang S I, Wigler M H, et al. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Nat Acad Sci USA 1997; 94: 9052–9057
   PubMed Web of Science ®Google Scholar
• Maehama T, Dixon J E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1998; 273: 13375–13378
   PubMed Web of Science ®Google Scholar
• Cantley L C. The phosphoinositide 3-kinase pathway. Science 2002; 296: 1655–1657
   PubMed Web of Science ®Google Scholar
• Chan T O, Rittenhouse S E, Tsichlis P N. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 1999; 68: 965–1014
   PubMed Web of Science ®Google Scholar
• Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor M K, Han K, et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 2002; 8: 1153–1160
   PubMed Web of Science ®Google Scholar
• Chu E C, Tarnawski A S. PTEN regulatory functions in tumor suppression and cell biology. Med Sci Monit 2004; 10: RA235–RA241
   PubMed Web of Science ®Google Scholar
• Ghobrial I M, Witzig T E, Adjei A A. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 2005; 55: 178–194
   PubMed Web of Science ®Google Scholar
• Sakai A, Thieblemont C, Wellmann A, Jaffe E S, Raffeld M. PTEN Gene Alterations in Lymphoid Neoplasms. Blood 1998; 92: 3410–3415
   PubMed Web of Science ®Google Scholar
• Abbott R T, Tripp S, Perkins S L, Elenitoba-Johnson K S, Lim M S. Analysis of the PI-3-Kinase-PTEN-AKT pathway in human lymphoma and leukemia using a cell line microarray. Mod Pathol 2003; 16: 607–612
   PubMed Web of Science ®Google Scholar
• Xu Z, Stokoe D, Kane L P, Weiss A. The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells. Cell Growth Differ 2002; 13: 285–296
   PubMedGoogle Scholar
• Shan X, Czar M J, Bunnell S C, Liu P, Liu Y, Schwartzberg P L, et al. Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 Stimulation. Mol Cell Biol 2000; 20: 6945–6957
   PubMed Web of Science ®Google Scholar
• Cohen G M. Caspases: the executioners of apoptosis. Biochem J 1997; 326((Part 1))1–16
   PubMed Web of Science ®Google Scholar
• McGowan C H. Regulation of the eukaryotic cell cycle. Prog Cell Cycle Res 2003; 5: 1–4
   PubMedGoogle Scholar
• Wu R C, Li X, Schonthal A H. Transcriptional activation of p21WAF1 by PTEN/MMAC1 tumor suppressor. Mol Cell Biochem 2000; 203: 59–71
   PubMed Web of Science ®Google Scholar